Alembic Pharmaceuticals Q3 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
825
-6.40 (-0.77%)
-6.40 (-0.77%)Volume48.88 K
Updated: Fri 14 Aug, 2026 | 15:29:55
NSE
825-6.20 (-0.75%)
-6.20 (-0.75%)Volume86.73 K
Updated: Fri 14 Aug, 2026 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,705.16 | 1,466.36 | 2.07% | 1,502.55 | 13.48% |
| Depreciation/ Amortization | 80.12 | 70.51 | 5.32% | 70.04 | 14.39% |
| Operating Income | 171.15 | 181.62 | -28.57% | 190.19 | -10.01% |
| Net Income | 132.98 | 153.40 | -28.01% | 138.42 | -3.93% |
| Other Operating Expenses Total | 621.13 | 588.13 | -3.10% | 595.45 | 4.31% |
| Net Income Before Taxes | 161.50 | 180.42 | -27.81% | 177.78 | -9.16% |
| Total Revenue | 1,876.31 | 1,647.98 | -1.77% | 1,692.74 | 10.84% |
| Selling/ General/ Admin Expenses Total | 432.71 | 391.47 | -1.10% | 397.52 | 8.85% |
| Diluted Normalized EPS | 8.51 | 7.24 | -9.42% | 7.01 | 21.46% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.